Volume 28, Issue 34 - December 1, 2010
ORIGINAL REPORTS
Multicenter Phase II Trial of S-1 in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
Seiji Naito, Masatoshi Eto, Nobuo Shinohara, Yoshihiko Tomita, Masato Fujisawa, Mikio Namiki, Masaharu Nishikido, Michiyuki Usami, Taiji Tsukamoto, and Hideyuki Akaza
[Abstract]
Impact of Overall Treatment Time on Survival and Local Control in Patients With Anal Cancer: A Pooled Data Analysis of Radiation Therapy Oncology Group Trials 87-04 and 98-11
Edgar Ben-Josef, Jennifer Moughan, Jaffer A. Ajani, Marshall Flam, Leonard Gunderson, JonDavid Pollock, Robert Myerson, Rani Anne, Seth A. Rosenthal, and Christopher Willett
[Abstract]
Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma
Andreas Josting, Horst Müller, Peter Borchmann, Joke W. Baars, Bernd Metzner, Hartmut Döhner, Igor Aurer, Lenka Smardova, Thomas Fischer, Dietger Niederwieser, Kerstin Schäfer-Eckart, Norbert Schmitz, Anna Sureda, Jan Glossmann, Volker Diehl, Daphne DeJong, Martin-Leo Hansmann, John Raemaekers, and Andreas Engert [Abstract]
Prospective Analysis of Hepatitis B Virus Reactivation in Patients With Diffuse Large B-Cell Lymphoma After Rituximab Combination Chemotherapy
Nozomi Niitsu, Yuki Hagiwara, Ken Tanae, Mika Kohri, and Naoki Takahashi [Abstract]
Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial
Antonio Palumbo, Sara Bringhen, Davide Rossi, Maide Cavalli, Alessandra Larocca, Roberto Ria, Massimo Offidani, Francesca Patriarca, Chiara Nozzoli, Tommasina Guglielmelli, Giulia Benevolo, Vincenzo Callea, Luca Baldini, Fortunato Morabito, Mariella Grasso, Giovanna Leonardi, Manuela Rizzo, Antonietta Pia Falcone, Daniela Gottardi, Vittorio Montefusco, Pellegrino Musto, Maria Teresa Petrucci, Giovannino Ciccone, and Mario Boccadoro [Abstract]
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
Alison T. Stopeck, Allan Lipton, Jean-Jacques Body, Guenther G. Steger, Katia Tonkin, Richard H. de Boer, Mikhail Lichinitser, Yasuhiro Fujiwara, Denise A. Yardley, María Viniegra, Michelle Fan, Qi Jiang, Roger Dansey, Susie Jun, and Ada Braun [Abstract]
Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors
Louise Bordeleau, Kathleen I. Pritchard, Charles L. Loprinzi, Marguerite Ennis, Olivera Jugovic, David Warr, Rashida Haq, and Pamela J. Goodwin [Abstract]
Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend Analysis
David Palma, Otto Visser, Frank J. Lagerwaard, Jose Belderbos, Ben J. Slotman, and Suresh Senan [Abstract]
Accrual Experience of National Cancer Institute Cooperative Group Phase III Trials Activated From 2000 to 2007
Edward L. Korn, Boris Freidlin, Margaret Mooney, and Jeffrey S. Abrams
[Abstract]
Serologic Antienzyme Rate of Epstein-Barr Virus DNase-Specific Neutralizing Antibody Segregates TNM Classification in Nasopharyngeal Carcinoma
Jie Xu, Xiang-Bo Wan, Xue-Fei Huang, K.C. Allen Chan, Ming-Huang Hong, Li-Hui Wang, Zi-Jie Long, Qing Liu, Min Yan, Y.M. Dennis Lo, Yi-Xin Zeng, and Quentin Liu
[Abstract]
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
Christoph Schuhmacher, Stephan Gretschel, Florian Lordick, Peter Reichardt, Werner Hohenberger, Claus F. Eisenberger, Cornelie Haag, Murielle E. Mauer, Baktiar Hasan, John Welch, Katja Ott, Arnulf Hoelscher, Paul M. Schneider, Wolf Bechstein, Hans Wilke, Manfred P. Lutz, Bernard Nordlinger, Eric Van Cutsem, Jörg R. Siewert, and Peter M. Schlag
[Abstract]
Phase III Trial Comparing Oral S-1 Plus Carboplatin With Paclitaxel Plus Carboplatin in Chemotherapy-Naïve Patients With Advanced Non–Small-Cell Lung Cancer: Results of a West Japan Oncology Group Study
Isamu Okamoto, Hiroshige Yoshioka, Satoshi Morita, Masahiko Ando, Koji Takeda, Takashi Seto, Nobuyuki Yamamoto, Hideo Saka, Kazuhiro Asami, Tomonori Hirashima, Shinzoh Kudoh, Miyako Satouchi, Norihiko Ikeda, Yasuo Iwamoto, Toshiyuki Sawa, Masaki Miyazaki, Kenji Tamura, Takayasu Kurata, Masahiro Fukuoka, and Kazuhiko Nakagawa
[Abstract]
Induction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced Head and Neck Cancer
Athanassios Argiris, Dwight E. Heron, Ryan P. Smith, Seungwon Kim, Michael K. Gibson, Stephen Y. Lai, Barton F. Branstetter, Donna M. Posluszny, Lin Wang, Raja R. Seethala, Sanja Dacic, William Gooding, Jennifer R. Grandis, Jonas T. Johnson, and Robert L. Ferris
[Abstract]
REVIEW ARTICLES
Strategies for Prolonged Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
Panos Fidias and Silvia Novello
[Abstract]
European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer
Dirk De Ruysscher, Corinne Faivre-Finn, Ursula Nestle, Coen W. Hurkmans, Cécile Le Péchoux, Allan Price, and Suresh Senan
[Abstract]
The Evolving Role of Histology in the Management of Advanced Non–Small-Cell Lung Cancer
Corey J. Langer, Benjamin Besse, Antonio Gualberto, Elizabeth Brambilla, and Jean-Charles Soria [Abstract]
